9 Meters Biopharma, Inc. (NMTR) stock falls in Pre-Market: Why is it so?
9 Meters Biopharma, Inc. (NASDAQ: NMTR), a clinical-stage biopharmaceutical company specializing in treatments for rare diseases with unmet medical attention. , announced that the Company’s Chief Executive Officer, John Temperato will report a corporate update at Oppenheimer’s Rare & Orphan Disease Summit. NMTR stock price declined adjacent to the news. At last check-in premarket trading, […]
Is This The Reason The NMTR Stock Increased By Almost 11%?
With over 13.78 million 9 Meters Biopharma Inc. (NASDAQ: NMTR) shares trading Wednesday and a closing price of $1.23 on the day, the market cap was approximately 308.20 million. The NMTR stock has shown a negative weekly performance of -9.56% whereas its price on 04/07/21 gained nearly 10.81%. Currently, there are 216.07M common shares of […]
That’s how 9 Meters Biopharma (NMTR) stock staying above the limits
A biotechnology firm, 9 Meters Biopharma (NMTR), focuses on patients with rare diseases and unmet needs. The company’s portfolio contains drug candidates with short bowel syndrome (SBS) and celiac disease. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. Recent Scores The Company with a Market Cap […]
Premarket Stock Gainers
Pre-market data show Xunlei Limited (NASDAQ:XNET) is 7.89% higher at $3.28. It recently closed at $3.04, fluctuating in a day’s range from $2.94 to $3.44 and a 52-week trading range of $2.38 to $5.94. 9 Meters Biopharma Inc. (NASDAQ:NMTR) is trading at $0.9 up with 19.21 percent or 0.15 point in pre-market trading today after […]
Here is the reason why 9 Meters Biopharma, Inc. (NMTR) stock rushed in the late trading session
9 Meters Biopharma, Inc. (NASDAQ:NMTR) shares surged 18.56 to $0.89 in the post-market session after the Company has announced that it has closed its previously announced underwritten public offering of 53,076,924 shares of its common stock, inclusive of the full over allotment option exercised by the underwriters for the price of $0.65 per share. About […]
